Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology
Kazuhisa Nakashima(Shimane University), Masakazu Abé(Hamamatsu University School of Medicine), Makoto Wada(Kitasato University), Kenji Okita(Otaru Municipal Hospital), Takako Eguchi Nakajima(St. Marianna University School of Medicine), Mayumi Noda(Chiba University), Chiyo K. Imamura(SHOWA Medical University), Kenjiro Aogi(Shikoku Cancer Center), Ayako Okuyama(St. Luke's International University), Nobuyuki Yamamoto(Wakayama Medical University), Yong-il Kim(Yodogawa Christian Hospital), Hirotoshi Iihara(Gifu University Hospital), Takahiro Higashi(Unknown), Keiko Iino(National College Of Nursing), Ayako Yokomizo(Kyoto University), Junichi Nishimura, Koji Matsumoto(WinnMed), Masayuki Takeda(Kindai University), Naoki Nakamura(St. Marianna University School of Medicine), Narikazu Boku(Tokyo University of Science), Yōko Matsumoto(The University of Tokyo), Ryuhei Tanaka(Saitama Medical University), Keiko Ozawa(National Cancer Research Institute), Tatsuo Akechi(Nagoya City University), Kazumi Hayashi(Jikei University School of Medicine), Eriko Satomi(National Cancer Centre Japan), Hidenori Sasaki(Fukuoka University Hospital), Michiyasu Murakami(Matsuyama Red Cross Hospital)
Cited by 1
Related Papers
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k